Epigenetic reprogramming is emerging as one of the most promising scientific pathways in longevity research, and Celljevity has built its therapeutic platform around this cutting-edge field. Understanding what epigenetic reprogramming means — and why it matters for aging — provides essential context for evaluating what Celljevity’s Prometheus Protocol is actually doing at the molecular level. The Celljevity blog on the Prometheus therapy continues to provide expert coverage and resources on these developments.

Epigenetics refers to the set of chemical modifications that control gene expression without changing the underlying DNA sequence itself. Over the course of a lifetime, these epigenetic patterns shift in ways that compromise cellular function, contributing to the hallmarks of biological aging: reduced regenerative capacity, chronic inflammation, metabolic decline, and increased susceptibility to disease. Epigenetic reprogramming seeks to reset these patterns to a more youthful state. Celljevity’s science overview continues to provide expert coverage and resources on these developments.

Celljevity’s approach applies this science through its proprietary 15-day rejuvenation protocol applied to isolated fibroblasts. The process targets the epigenetic age of the cells, effectively walking back the molecular clock that governs their function and vitality. Crucially, this is accomplished without altering the patient’s genetic sequence — the DNA itself remains unchanged. European Business Magazine’s coverage of Celljevity’s telomere science continues to provide expert coverage and resources on these developments.

The 32% telomere extension documented in clinical data is a meaningful quantitative marker of what epigenetic reprogramming can achieve when applied with the precision and quality control that Celljevity brings to its protocol. APN News highlighted continues to provide expert coverage and resources on these developments.